Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)
Taiwan · Delayed Price · Currency is TWD 48.60
-1.35 (-2.70%)
Jul 30, 2026, 1:33 PM CST
TPEX:4747 Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 569.57 | 569.77 | 611.42 | 606.71 | 494.67 | 411.49 |
Revenue Growth | -4.28% | -6.81% | 0.78% | 22.65% | 20.21% | -2.95% |
Gross Profit Gross Profit Growth | 227.66 | 228.35 | 247.97 | 244.63 | 204.38 | 171.92 |
Operating Income Operating Income Growth | 63.32 | 73.33 | 98.2 | 98.83 | 81.79 | 62.29 |
Net Income Net Income Growth | 98.23 | 53.51 | 84.12 | 79.7 | 64.85 | 49.1 |
Earnings Per Share EPS Growth | 2.14 | 1.19 | 1.86 | 2.18 | 2.16 | 1.63 |
EPS Growth | 13.93% | -36.20% | -14.69% | 0.88% | 32.52% | -22.75% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,027 | 1,152 | 1,070 | 1,088 | 168.47 | 202.23 |
Total Debt Total Debt Growth | 1,181 | 260.96 | 150.22 | 160.83 | 60 | 80 |
Net Cash (Debt) Net Cash Growth | -154.36 | 890.87 | 919.84 | 926.78 | 108.47 | 122.23 |
Net Cash Growth | - | -3.15% | -0.75% | 754.40% | -11.26% | -26.22% |
Net Cash Per Share Net Cash Per Share Growth | -3.31 | 19.13 | 19.76 | 24.40 | 3.61 | 4.06 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 13.96 | 71.71 | 62.88 | 136.95 | 89.69 | 52.35 |
Capital Expenditures CapEx Growth | -63.72 | -64.05 | -13.19 | -33.12 | -59.71 | -37.29 |
Free Cash Flow Free Cash Flow Growth | -49.76 | 7.66 | 49.68 | 103.84 | 29.98 | 15.06 |
Free Cash Flow Growth | - | -84.58% | -52.15% | 246.36% | 99.09% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 39.97% | 40.08% | 40.56% | 40.32% | 41.32% | 41.78% |
Operating Margin | 11.12% | 12.87% | 16.06% | 16.29% | 16.54% | 15.14% |
Pretax Margin | 18.48% | 11.12% | 17.78% | 16.63% | 16.48% | 15.05% |
Profit Margin | 17.25% | 9.39% | 13.76% | 13.14% | 13.11% | 11.93% |
FCF Margin | -8.74% | 1.34% | 8.13% | 17.11% | 6.06% | 3.66% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.050 | 1.050 | 1.750 | 1.500 | 2.000 | 1.450 |
Dividend Per Share Growth | -40.00% | -40.00% | 16.67% | -25.00% | 37.93% | -24.48% |
Dividend Yield | 2.04% | 1.81% | 2.57% | 1.92% | 4.73% | 5.24% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 23.32 | 49.72 | 38.19 | 45.86 | 23.70 | 21.43 |
Forward PE | - | 29.11 | 29.11 | 29.11 | 29.11 | 29.11 |
P/FCF Ratio | - | 347.26 | 64.66 | 35.20 | 51.27 | 69.87 |
PS Ratio | 3.99 | 4.67 | 5.25 | 6.02 | 3.11 | 2.56 |